Guardant Health (GH) Long-Term Investments (2017 - 2022)
Guardant Health (GH) has disclosed Long-Term Investments for 6 consecutive years, with $156.7 million as the latest value for Q3 2022.
- Quarterly Long-Term Investments fell 37.36% to $156.7 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $156.7 million through Sep 2022, down 37.36% year-over-year, with the annual reading at $698.0 million for FY2021, 183.07% up from the prior year.
- Long-Term Investments hit $156.7 million in Q3 2022 for Guardant Health, down from $382.6 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $698.0 million in Q4 2021 to a low of $3.0 million in Q3 2018.
- Historically, Long-Term Investments has averaged $235.6 million across 5 years, with a median of $242.4 million in 2020.
- Biggest five-year swings in Long-Term Investments: soared 10113.43% in 2019 and later tumbled 83.02% in 2020.
- Year by year, Long-Term Investments stood at $77.6 million in 2018, then surged by 246.54% to $268.8 million in 2019, then decreased by 8.25% to $246.6 million in 2020, then soared by 183.07% to $698.0 million in 2021, then crashed by 77.55% to $156.7 million in 2022.
- Business Quant data shows Long-Term Investments for GH at $156.7 million in Q3 2022, $382.6 million in Q2 2022, and $588.5 million in Q1 2022.